Handa Pharma https://validator.w3.org/feed/docs/rss2.html Pipeline Products HOME Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets Corporate Structure Investor Relations INVESTORS Our Company Drug Delivery Technologies & Pipeline ABOUT HANDA RECENT NEWS Partnering CONTACT Resources PIPELINE History Leadership Team RESEARCH & DEVELOPMENT CAREERS